Marvell Technology, Inc. vs Microsoft Corporation — Stock Comparison
Q·Score Breakdown
7.6
Buy
Overall
8.9
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
MRVL
Earnings growing 106% year-over-year on 22% revenue growth.
⚠ analysts see limited upside from current price.
MSFT
Analysts see 42% upside to $570.72 consensus target.
Analyst Consensus
BUY
Target $128.36 (-21.6%)
39 analysts
BUY
Target $570.72 (+41.5%)
54 analysts
Fundamentals
MRVL
MSFT
53.3×
Trailing P/E
25.3×
30.2×
Forward P/E
21.0×
32.6%
Profit Margin
39.0%
51.0%
Gross Margin
68.6%
19.3%
ROE
34.4%
22.1%
Revenue Growth
16.7%
106.3%
Earnings Growth
59.8%
1.82
Beta
1.11
—
Price / Book
—
$143.1B
Market Cap
$3.00T
$54 – $171
52-Week Range
$356 – $555
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.